Open Clinical Trials
To enroll in a cancer clinical trial at Childrens Hospital Los Angeles' Childrens Center for Cancer and Blood Diseases, please contact:
Heidi Kristall RN, BSN, CPON
New Referrals Nurse
(323) 361-4100
Leukemia/Lymphoma Program
CCG 1991: Escalating Dose Intravenous Methotrexate Without Leucovorin Rescue vs. Oral Methotrexate and Single vs. Double Delayed Intensification for Children with Standard Risk Acute Lymphoblastic Leukemia
99LA011: Phase I Study of 6-Thioguanine, Followed by Continuous Infusion of Cytosine Arabinoside, Followed By Intramuscular PEG in Children with Refractory ALL, ANLL and NHL with Marrow Involvement
99LA037: An Ascending Dose Study of the Safety of CMA-676 as a Single Agent Treatment of Pediatric Patients with Refractory or Relapsed Acute Myelogenous Leukemia
99LA137: Treatment of Childhood Acute Lymphoblastic Leukemia and an Initial Bone Marrow Relapse within 12 months of the Completion of Therapy: A Feasibility Study
Neural Tumor Program (Brain Tumors, Neuroblastoma, Retinoblastoma, ABMT)
CCG A3961: Treatment for Infants and Children with Intermediate Risk Neuroblastoma
CCG P9641: Primary Surgical Therapy for Biologically Defined Low Risk Neuroblastoma: A Pediatric Oncology Group/Childrens Cancer Group Intergroup Study
CCG 99703: A Pilot Study of Intensive Chemotherapy with Peripheral Stem Cell Support in Infants with Malignant Brain Tumors
CCG 9952: Chemotherapy for Progressive Low Grade Astrocytoma in Children Less than Ten Years Old
CCG A9961: Phase III Prospective Randomized Study of Craniospinal Radiation Therapy Followed by 1 of 2 Adjuvant Chemo Regimens for Newly Diagnosed Average Risk Medulloblastoma
CCG 99702: Treatment for High Risk Medulloblastoma and Supratentorial PNET's with Induction, Conventional Radiation Therapy, and Intensive consolidation with PBPC Support
99LA040: A Phase I/II Study of Chemotherapy with Sequential Local Therapy for Children with Intraocular Retinoblastoma
CCG 09712: Gadolinium-Texaphyrin and Involved Field Radiation Therapy for Instrinsic Pontine Glioma of Childhoond
96LA4: Poly ICLC in Management of Newly Diagnosed Malignant Gliomas and Recurrent Pediatric Brain Tumors
99LA094: Neoadjuvant Chemotherapy and Reduced Dose Radiation Therapy for Newly Diagnosed Primary Intracranial Germinoma Germ Cell Tumors
2000LA40: Modulation of Intensive Melphalan (L-PAM) by Buthionine Sulfoximine (BXO) Autologous Stem Cell Support for Pediatric Extracranial Solid Tumors NIC #68
Bone and Soft Tissue Program
CCG D9602: IRS V Protocol of Actinomycin D and VCR with or without CPM and RT, for Newly Diagnosed Patients with Low Risk Rhabdomyosarcoma or Undifferentiated Sarcomas: IRS V Protocol
CCG 0962: Phase II Study of Docetaxel (Taxotere) in Children with Recurrent Solid Tumors
CCG 09705: Phase II Evaluation of Intravenous Navelbine (Vinorelbine) in Recurrent or Refractory Pediatric Malignancies
|
